Cellebrite DI Ltd. (CLBT)
(Delayed Data from NSDQ)
$16.64 USD
+0.13 (0.79%)
Updated Sep 11, 2024 04:00 PM ET
After-Market: $16.65 +0.01 (0.06%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth B Momentum B VGM
Balance Sheet
Fiscal Year End for Cellebrite DI Ltd falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 303 | 184 | 182 | 1 | 0 |
Receivables | 77 | 79 | 68 | 0 | 0 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 10 | 10 | 7 | 0 | 0 |
Other Current Assets | 32 | 23 | 18 | 0 | 0 |
Total Current Assets | 422 | 296 | 273 | 2 | 0 |
Net Property & Equipment | 16 | 17 | 17 | 0 | 0 |
Investments & Advances | 29 | 22 | 0 | 600 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 7 | 13 | 10 | 0 | 0 |
Intangibles | 37 | 38 | 38 | 0 | 0 |
Deposits & Other Assets | 7 | 2 | 2 | 0 | 0 |
Total Assets | 533 | 403 | 340 | 602 | 0 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 53 | 50 | 64 | 0 | 0 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 196 | 153 | 123 | 0 | 0 |
Total Current Liabilities | 254 | 208 | 187 | 0 | 0 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 47 | 42 | 36 | 21 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 189 | 69 | 190 | 576 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 499 | 329 | 413 | 597 | 0 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | -85 | -126 | -153 | 5 | 0 |
Retained Earnings | 118 | 199 | 78 | 0 | 0 |
Other Equity | 1 | 0 | 1 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 34 | 74 | -73 | 5 | 0 |
Total Liabilities & Shareholder's Equity | 533 | 403 | 340 | 602 | 0 |
Total Common Equity | 34 | 74 | -73 | 5 | 0 |
Shares Outstanding | 188.50 | 189.60 | 187.10 | 17.40 | NA |
Book Value Per Share | 0.18 | 0.39 | -0.39 | 0.29 | 0.00 |
Fiscal Year End for Cellebrite DI Ltd falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 305 | 277 | 303 | 264 | 237 |
Receivables | 71 | 62 | 77 | 70 | 61 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 9 | 9 | 10 | 11 | 11 |
Other Current Assets | 30 | 31 | 32 | 30 | 28 |
Total Current Assets | 415 | 378 | 422 | 374 | 337 |
Net Property & Equipment | 16 | 16 | 16 | 15 | 16 |
Investments & Advances | 61 | 71 | 29 | 19 | 7 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 9 | 8 | 7 | 10 | 12 |
Intangibles | 37 | 37 | 37 | 38 | 36 |
Deposits & Other Assets | 8 | 7 | 7 | 8 | 3 |
Total Assets | 557 | 529 | 533 | 477 | 426 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 49 | 44 | 53 | 51 | 41 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 184 | 186 | 196 | 171 | 159 |
Total Current Liabilities | 237 | 235 | 254 | 227 | 205 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 42 | 42 | 47 | 48 | 47 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 310 | 189 | 157 | 148 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 597 | 556 | 499 | 439 | 408 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | -64 | -75 | -85 | -95 | -108 |
Retained Earnings | 23 | 47 | 118 | 133 | 126 |
Other Equity | 1 | 1 | 1 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | -40 | -27 | 34 | 38 | 18 |
Total Liabilities & Shareholder's Equity | 557 | 529 | 533 | 477 | 426 |
Total Common Equity | -40 | -27 | 34 | 38 | 18 |
Shares Outstanding | 205.90 | 205.30 | 188.50 | 194.60 | 194.60 |
Book Value Per Share | -0.20 | -0.13 | 0.18 | 0.19 | 0.09 |